Community LRTI Pneumonia Intravenous Antibiotic pathway for Housebound Care Home patients Pathway

1) This is an exceptional pathway. It will only be suitable for housebound and care home patients to avoid hospital admission. A doctor needs to have done an assessment to determine suitability for this pathway.  This is for prevention of admission during the COVID-19 pandemic. Prescribing follows NICE Guidance NG173 

2) This is a guide, and all management plans need to be reviewed on a regular basis, particularly with potential COVID-19 co-morbidity.

3) The POA service document must be adhered to. This includes ensuring staff IV drug competencies and access to information resources regarding administration, and also governance issues including management of scenarios such as anaphylactic reaction to drugs.

4) This pathway does NOT cover any oxygen monitoring or use.